Source:http://linkedlifedata.com/resource/pubmed/id/20960174
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-10-20
|
pubmed:abstractText |
The hypothalamic damage induced by neonatal treatment with monosodium L -glutamate (MSG) induces several metabolic abnormalities, resulting in a rat hyperleptinemic-hyperadipose phenotype. This study was conducted to explore the impact of the neonatal MSG treatment, in the adult (120 days old) female rat on: (a) the in vivo and in vitro mineralocorticoid responses to ACTH and angiotensin II (AII); (b) the effect of leptin on ACTH- and AII-stimulated mineralocorticoid secretions by isolated corticoadrenal cells; and (c) abdominal adiposity characteristics. Our data indicate that, compared with age-matched controls, MSG rats displayed: (1) enhanced and reduced mineralocorticoid responses to ACTH and AII treatments, respectively, effects observed in both in vivo and in vitro conditions; (2) adrenal refractoriness to the inhibitory effect of exogenous leptin on ACTH-stimulated aldosterone output by isolated adrenocortical cells; and (3) distorted omental adiposity morphology and function. This study supports that the adult hyperleptinemic MSG female rat is characterized by enhanced ACTH-driven mineralocorticoid function, impaired adrenal leptin sensitivity, and disrupted abdominal adiposity function. MSG rats could counteract undesirable effects of glucocorticoid excess, by developing a reduced AII-driven mineralocorticoid function. Thus, chronic hyperleptinemia could play a protective role against ACTH-mediated allostatic loads in the adrenal leptin resistant, MSG female rat phenotype.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1559-0100
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
497-506
|
pubmed:meshHeading |
pubmed-meshheading:20960174-Adiposity,
pubmed-meshheading:20960174-Adrenal Cortex,
pubmed-meshheading:20960174-Adrenocorticotropic Hormone,
pubmed-meshheading:20960174-Aldosterone,
pubmed-meshheading:20960174-Angiotensin II,
pubmed-meshheading:20960174-Animals,
pubmed-meshheading:20960174-Animals, Newborn,
pubmed-meshheading:20960174-Female,
pubmed-meshheading:20960174-Hypothalamus,
pubmed-meshheading:20960174-Omentum,
pubmed-meshheading:20960174-Phenotype,
pubmed-meshheading:20960174-Rats,
pubmed-meshheading:20960174-Rats, Sprague-Dawley,
pubmed-meshheading:20960174-Sodium Glutamate
|
pubmed:year |
2010
|
pubmed:articleTitle |
Analysis of angiotensin II- and ACTH-driven mineralocorticoid functions and omental adiposity in a non-genetic, hyperadipose female rat phenotype.
|
pubmed:affiliation |
Neuroendocrine Unit, Multidisciplinary Institute on Cell Biology (CONICET-CICPBA), PO Box 403, 1900 La Plata, Argentina.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|